
NervGen Pharma Corp. Common stock
NGENHealthcare|Biotechnology|CA
$1.33
+0.01 (+0.76%)
DCF Value
$0.17
Tangible Book / Share
$0.18
Cash / Share
$0.94
Next Earnings Report
Nov 12, 2026
EPS est. -$0.10
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest May 26, 2026 (F-10). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments
Sep 25, 2026 · GlobeNewsWire
NervGen to Host Inaugural R&D Day on September 30, 2026
Sep 9, 2026 · GlobeNewsWire
NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates
Aug 13, 2026 · GlobeNewsWire
SEC Filings (32)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 16, 2026 | 6-K/A | Foreign issuer report | DocumentIndex |
| Oct 16, 2026 | 40-F/A | Annual report (foreign) | DocumentIndex |
| Sep 25, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 24, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 13, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 2, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 2, 2026 | SUPPL | DocumentIndex | |
| Jun 1, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 26, 2026 | EFFECT | DocumentIndex | |
| May 26, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 26, 2026 | SUPPL | DocumentIndex | |
| May 26, 2026 | F-X | DocumentIndex | |
| May 26, 2026 | F-10 | IPO / offering registration | DocumentIndex |
| May 22, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 22, 2026 | SUPPL | DocumentIndex | |
| May 21, 2026 | SUPPL | DocumentIndex | |
| May 18, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 15, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 7, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Apr 27, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 31, 2026 | 40-F | Annual report (foreign) | DocumentIndex |
| Mar 13, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Feb 13, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Feb 10, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jan 23, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jan 8, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jan 7, 2026 | EFFECT | DocumentIndex | |
| Jan 7, 2026 | CERT | DocumentIndex | |
| Jan 7, 2026 | 8-A12B | DocumentIndex | |
| Jan 7, 2026 | F-10/A | IPO / offering registration | DocumentIndex |
| Dec 17, 2025 | F-X | DocumentIndex | |
| Dec 17, 2025 | F-10 | IPO / offering registration | DocumentIndex |